Chong Kun Dang Pharmaceutical Corp
KRX:185750

Watchlist Manager

Chong Kun Dang Pharmaceutical Corp

KRX:185750

Watchlist

Dividends

Discount Rate

Price: 94 000 KRW -0.63% Market Closed

Market Cap: 1.2T KRW

Have any thoughts about
Chong Kun Dang Pharmaceutical Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 94000 KRW

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

Alert

Chong Kun Dang Pharmaceutical Corp

94000

-600 (-0.63%)

52 Week Range	94 000 133 000
Price Target

We'll email you a reminder when the closing price reaches KRW.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Chong Kun Dang Pharmaceutical Corp

What unique competitive advantages
does Chong Kun Dang Pharmaceutical Corp hold over its rivals?

What risks and challenges
does Chong Kun Dang Pharmaceutical Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Chong Kun Dang Pharmaceutical Corp.

What unique competitive advantages
does Chong Kun Dang Pharmaceutical Corp hold over its rivals?

What risks and challenges
does Chong Kun Dang Pharmaceutical Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Chong Kun Dang Pharmaceutical Corp.

Provide P/S
for Chong Kun Dang Pharmaceutical Corp.

Provide P/E
for Chong Kun Dang Pharmaceutical Corp.

Provide P/OCF
for Chong Kun Dang Pharmaceutical Corp.

Provide P/FCFE
for Chong Kun Dang Pharmaceutical Corp.

Provide P/B
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/S
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/GP
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/EBITDA
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/EBIT
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/OCF
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/FCFF
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/IC
for Chong Kun Dang Pharmaceutical Corp.

Show me price targets
for Chong Kun Dang Pharmaceutical Corp made by professional analysts.

What are the Revenue projections
for Chong Kun Dang Pharmaceutical Corp?

How accurate were the past Revenue estimates
for Chong Kun Dang Pharmaceutical Corp?

What are the Net Income projections
for Chong Kun Dang Pharmaceutical Corp?

How accurate were the past Net Income estimates
for Chong Kun Dang Pharmaceutical Corp?

What are the EPS projections
for Chong Kun Dang Pharmaceutical Corp?

How accurate were the past EPS estimates
for Chong Kun Dang Pharmaceutical Corp?

What are the EBIT projections
for Chong Kun Dang Pharmaceutical Corp?

How accurate were the past EBIT estimates
for Chong Kun Dang Pharmaceutical Corp?

Compare the revenue forecasts
for Chong Kun Dang Pharmaceutical Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Chong Kun Dang Pharmaceutical Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Chong Kun Dang Pharmaceutical Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Chong Kun Dang Pharmaceutical Corp compared to its peers.

Compare the P/E ratios
of Chong Kun Dang Pharmaceutical Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Chong Kun Dang Pharmaceutical Corp with its peers.

Analyze the financial leverage
of Chong Kun Dang Pharmaceutical Corp compared to its main competitors.

Show all profitability ratios
for Chong Kun Dang Pharmaceutical Corp.

Provide ROE
for Chong Kun Dang Pharmaceutical Corp.

Provide ROA
for Chong Kun Dang Pharmaceutical Corp.

Provide ROIC
for Chong Kun Dang Pharmaceutical Corp.

Provide ROCE
for Chong Kun Dang Pharmaceutical Corp.

Provide Gross Margin
for Chong Kun Dang Pharmaceutical Corp.

Provide Operating Margin
for Chong Kun Dang Pharmaceutical Corp.

Provide Net Margin
for Chong Kun Dang Pharmaceutical Corp.

Provide FCF Margin
for Chong Kun Dang Pharmaceutical Corp.

Show all solvency ratios
for Chong Kun Dang Pharmaceutical Corp.

Provide D/E Ratio
for Chong Kun Dang Pharmaceutical Corp.

Provide D/A Ratio
for Chong Kun Dang Pharmaceutical Corp.

Provide Interest Coverage Ratio
for Chong Kun Dang Pharmaceutical Corp.

Provide Altman Z-Score Ratio
for Chong Kun Dang Pharmaceutical Corp.

Provide Quick Ratio
for Chong Kun Dang Pharmaceutical Corp.

Provide Current Ratio
for Chong Kun Dang Pharmaceutical Corp.

Provide Cash Ratio
for Chong Kun Dang Pharmaceutical Corp.

What is the historical Revenue growth
over the last 5 years for Chong Kun Dang Pharmaceutical Corp?

What is the historical Net Income growth
over the last 5 years for Chong Kun Dang Pharmaceutical Corp?

What is the current Free Cash Flow
of Chong Kun Dang Pharmaceutical Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Chong Kun Dang Pharmaceutical Corp.

P/OCF
Price to OCF

4.6

Current

6.1

Median

16.5

Industry

Lower than median

Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF

4.6

Market Cap

1.2T KRW

Operating Cash Flow

257.8B KRW

All Countries

Forward Multiples

			Market Cap	P/OCF
KR		Chong Kun Dang Pharmaceutical Corp KRX:185750	1.2T KRW	4.6
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-19 905 436.7
US		Eli Lilly and Co NYSE:LLY	710.5B USD	117.8
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	6 923.9
DK		Novo Nordisk A/S CSE:NOVO B	3.3T DKK	28.1
US		Johnson & Johnson NYSE:JNJ	373.5B USD	14.9
US		Merck & Co Inc NYSE:MRK	251.1B USD	13.7
CH		Roche Holding AG SIX:ROG	202.7B CHF	12.6
CH		Novartis AG SIX:NOVN	183.3B CHF	12.3
UK		AstraZeneca PLC LSE:AZN	162.4B GBP	18.4
IE	E	Endo International PLC LSE:0Y5F	146B USD	542.3


KR		Chong Kun Dang Pharmaceutical Corp KRX:185750	Average P/OCF: 768.9 4.6
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -19 905 436.7
US		Eli Lilly and Co NYSE:LLY	117.8
UK		Dechra Pharmaceuticals PLC LSE:DPH	6 923.9
DK		Novo Nordisk A/S CSE:NOVO B	28.1
US		Johnson & Johnson NYSE:JNJ	14.9
US		Merck & Co Inc NYSE:MRK	13.7
CH		Roche Holding AG SIX:ROG	12.6
CH		Novartis AG SIX:NOVN	12.3
UK		AstraZeneca PLC LSE:AZN	18.4
IE	E	Endo International PLC LSE:0Y5F	542.3

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/OCF

N/A

2-Years Forward

P/OCF

N/A

3-Years Forward

P/OCF

N/A

Chong Kun Dang Pharmaceutical Corp
KRX:185750

P/OCF
Price to OCF

P/OCF Forward Multiples

See Also

Company

Help

Tools

Stocks

Chong Kun Dang Pharmaceutical Corp KRX:185750

P/OCF Price to OCF

P/OCF Forward Multiples

See Also

Company

Help

Tools

Stocks

Chong Kun Dang Pharmaceutical Corp
KRX:185750

P/OCF
Price to OCF